Monoclonal antibodies (mAbs) offer a treatment option for individuals with severe COVID-19
and are especially important in high-risk individuals where vaccination is not an option …

Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …

SARS-CoV-2 variants acquire mutations in the spike protein that promote immune evasion
and affect other properties that contribute to viral fitness, such as ACE2 receptor binding and …

Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention,
Shandong and else where. BQ. 1.1 and XBB possess substitutions relative to BA. 5 and BA …

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6 | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Abstract The SARS-CoV-2 Omicron variant containing 15 mutations, including the unique
Q493R, in the spike protein receptor binding domain (S1-RBD) is highly infectious. While …

We are amid the historic coronavirus infectious disease 2019 (COVID-19) pandemic.
Imbalances in the accessibility of vaccines, medicines, and diagnostics among countries …

SARS-CoV-2 variants acquire mutations in spike that promote immune evasion and impact
other properties that contribute to viral fitness such as ACE2 receptor binding and cell entry …

The global scale of the COVID-19 pandemic has demonstrated the evolution of SARS-CoV-
2 and the clues of adaptation. After two years and two months since the declaration of the …

Several subvariants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant have evolved very quickly and are also evolving continuously. Notably …